Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in ADCT — ADC Therapeutics SA

CIK 902219 Boston, MA
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$250,758
-$615,731 QoQ
Shares Held
234,355
+1.4% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 113 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority Sole 0% Shared 64% None 36%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. ADCT ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in ADCT

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $250,758 234,355
2026-03-31 $866,489 231,064
2025-12-31 $751,589 212,915
2025-09-30 $1,000,336 250,084
2024-12-31 $504,150 253,342
2024-09-30 $530,953 168,557